Neurological implications of urea cycle disorders

Neurological implications of urea cycle disorders

Gardado en:

Detalles Bibliográficos
Main Authors:	Andrea Gropman, Marshall Summar, James V. Leonard
Formato:	Revisão
Idioma:	inglés
Publicado:	2007
Acceso en liña:	https://doi.org/10.1007/s10545-007-0709-5 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1007/s10545-007-0709-5
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares

Neurological implications of urea cycle disorders
por: Gropman, A. L., et al.
Publicado: (2007)

Brain imaging in urea cycle disorders
por: Andrea Gropman
Publicado: (2010)

Brain imaging in Urea cycle disorders
por: Gropman, Andrea
Publicado: (2010)

Improving Long Term Outcomes in Urea Cycle Disorders-Report from the Urea Cycle Disorders Consortium
por: Waisbren, Susan, et al.
Publicado: (2016)

Improving long term outcomes in urea cycle disorders‐report from the Urea Cycle Disorders Consortium
por: Susan E. Waisbren, et al.
Publicado: (2016)

A longitudinal study of urea cycle disorders
por: Mark L. Batshaw, et al.
Publicado: (2014)

A longitudinal study of urea cycle disorders
por: Batshaw, Mark L., et al.
Publicado: (2014)

The incidence of urea cycle disorders
por: Marshall Summar, et al.
Publicado: (2013)

The incidence of urea cycle disorders
por: Summar, Marshall L., et al.
Publicado: (2013)

On the Creation, Utility and Sustaining of Rare Diseases Research Networks: Lessons learned from the Urea Cycle Disorders Consortium, the Japanese Urea Cycle Disorders Consortium and the European Registry and Network for Intoxication Type Metabolic Diseases
por: Summar, Marshall L., et al.
Publicado: (2014)

Multimodal imaging in urea cycle-related neurological disease – What can imaging after hyperammonemia teach us?
por: Sen, Kuntal, et al.
Publicado: (2020)

Vaccines Are Not Associated With Metabolic Events in Children With Urea Cycle Disorders
por: Morgan, Thomas M., et al.
Publicado: (2011)

Infectious precipitants of acute hyperammonemia are associated with indicators of increased morbidity in patients with Urea Cycle Disorders
por: Mc Guire, Peter J., et al.
Publicado: (2013)

Peptide tyrosine tyrosine levels are increased in patients with urea cycle disorders
por: Mitchell, Sabrina, et al.
Publicado: (2012)

Advances in Urea cycle Neuroimaging: Proceedings from the 4th International symposium on Urea cycle disorders, Barcelona, Spain, September 2013
por: Pacheco-Colon, Ileana, et al.
Publicado: (2014)

Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue
por: Sen, Kuntal, et al.
Publicado: (2021)

Fifteen years of urea cycle disorders brain research: Looking back, looking forward
por: Sen, Kuntal, et al.
Publicado: (2021)

Urea cycle defects and hyperammonemia: effects on functional imaging
por: Gropman, Andrea L., et al.
Publicado: (2012)

Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21‐year, multicentre study of acute hyperammonaemic episodes
por: Marshall Summar, et al.
Publicado: (2008)

Diagnosis, Symptoms, Frequency and Mortality of 260 Patients with Urea Cycle Disorders from a 21-Year, Multicentre Study of Acute Hyperammonaemic Episodes
por: Summar, Marshall L., et al.
Publicado: (2008)

Mitochondrial Mechanisms and Neurological Disorders
por: Gropman, Andrea L.
Publicado: (2013)

Networking Across Borders for Individuals with Organic Acidurias and Urea Cycle Disorders: The E-IMD Consortium
por: Kölker, Stefan, et al.
Publicado: (2015)

Quantitative RT-PCR Comparison of the Urea and Nitric Oxide Cycle Gene Transcripts in Adult Human Tissues
por: Neill, Meaghan Anne, et al.
Publicado: (2009)

Cross-sectional multicenter study of patients with urea cycle disorders in the United States
por: Mendel Tuchman, et al.
Publicado: (2008)

Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders
por: Roland Posset, et al.
Publicado: (2019)

Impact of diagnosis and therapy on cognitive function in urea cycle disorders
por: Posset, Roland, et al.
Publicado: (2019)

Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders
por: Masoud Mokhtarani, et al.
Publicado: (2012)

Cross-Sectional Multi-Center Study of Patients with Urea Cycle Disorders in the United States
por: Tuchman, Mendel, et al.
Publicado: (2008)

Neurologic Outcome of Urea Cycle Disorder Liver Transplant Recipients May Be Predicted by Pre-Transplant Neurological Imaging
por: Bolton, Scott M., et al.
Publicado: (2015)

Long-term effects of medical management on growth and weight in individuals with urea cycle disorders
por: Posset, Roland, et al.
Publicado: (2020)

Urinary Phenylacetylglutamine as Dosing Biomarker for Patients with Urea Cycle Disorders
por: Mokhtarani, M, et al.
Publicado: (2012)

In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle
por: Lee, Brendan, et al.
Publicado: (2000)

Establishing a Consortium for the Study of Rare Diseases: The Urea Cycle Disorders Consortium
por: Seminara, Jennifer, et al.
Publicado: (2010)

Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders
por: Posset, Roland, et al.
Publicado: (2020)

Prospective treatment of urea cycle disorders
por: Nancy E. Maestri, et al.
Publicado: (1991)

Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium
por: Jennifer Seminara, et al.
Publicado: (2010)

Role of infection in urea cycle disorders
Publicado: (2014)

Hepatic Manifestations of Urea Cycle Disorders
por: Strong, Alanna, et al.
Publicado: (2021)

BLOOD AMMONIA AND GLUTAMINE AS PREDICTORS OF HYPERAMMONEMIC CRISES IN UREA CYCLE DISORDER PATIENTS
por: Lee, Brendan, et al.
Publicado: (2014)

The Urea Cycle
por: Seashore, Margretta R.
Publicado: (1978)